HSP90α-USP7-DNMT1 axis drives HCC recurrence after microwave ablation by disrupting ACSS3-mediated propionate

Ye Chen1, Jiaxin Bei2, Xinkun Huang1

  • 1Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China; Guangdong Engineering Technology Research Center of Interventional Oncology and Precision Drug Delivery, Guangzhou 510260, China.

Insights

Insufficient microwave ablation for liver cancer (HCC) triggers DNA changes that promote recurrence. Targeting these epigenetic and metabolic shifts with gene editing and propionate supplementation offers a new strategy to prevent cancer regrowth.

Area of Science:

  • Oncology
  • Epigenetics
  • Metabolic Regulation

Background:

  • Hepatocellular carcinoma (HCC) recurrence after insufficient microwave ablation (iMWA) is a significant clinical challenge.
  • Sublethal heat stress from iMWA activates aberrant cellular mechanisms promoting residual tumor growth and invasion.

Purpose of the Study:

  • To elucidate the epigenetic and metabolic alterations driving HCC recurrence post-iMWA.
  • To investigate the role of DNA methyltransferase 1 (DNMT1) in mediating these changes.
  • To develop and evaluate a novel epigenetic therapy targeting ACSS3 for preventing HCC recurrence.

Main Methods:

  • Analysis of DNA methylation machinery and heat-shock protein interactions in residual HCC.
  • Investigated the impact of DNMT1 upregulation on propionate metabolism and fatty acid oxidation (FAO).
  • Developed and tested a liposomal CRISPR/dCas9 system for locus-specific ACSS3 demethylation in a preclinical setting.

Main Results:

  • Sublethal heat stress activates HSP90α/USP7/DNMT1 axis, increasing DNA methylation in residual HCC.
  • DNMT1-mediated silencing of ACSS3 impairs propionate metabolism, enhancing FAO-dependent ATP production and tumor growth.
  • CRISPR/dCas9-mediated ACSS3 reactivation, especially with propionate supplementation, effectively prevented HCC recurrence and metastasis.

Conclusions:

  • A novel DNMT1-driven epigenetic-metabolic cascade promotes HCC recurrence after iMWA.
  • Targeting ACSS3 methylation editing represents a promising therapeutic strategy for liver cancer.
  • Combination therapy with propionate supplementation enhances the efficacy of epigenetic interventions.

Related Concept Videos